The Groundbreaking Research That Changes Everything A landmark clinical study published in July 2025 in The American Journal of the Medical Sciences by Dr
This review study highlights the molecular and clinical evidence suggesting boosting GSH protects against oxidative stress, inflammation, and multiple aspects of age-related decline
Published March 26, 2020 - More info Semaglutide, a glucagon-like peptide 1 (GLP-1) analog, induces weight loss, lowers glucose levels, and reduces cardiovascular risk in patients with diabetes
A dose administered during the course of the day promotes improved sleep on the subsequent night and for several nights thereafter a temporal profile incompatible with direct sedation and consistent with a neuromodulatory mechanism acting on sleep homeostatic systems
Am J Transplant 2008
16, 2025 from MotherToBaby Fact Sheet